SciELO - Scientific Electronic Library Online

 
vol.24 número5Tablas de percentiles del tercer ventrículo según edad y sexo asociado al envejecimiento cerebralCuestionario de rendimiento laboral posterior al retorno al trabajo en pacientes sobrevivientes a infarto cerebral: el cuestionario WPQ-INNN índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

  • No hay artículos similaresSimilares en SciELO

Compartir


Revista mexicana de neurociencia

versión On-line ISSN 2604-6180versión impresa ISSN 1665-5044

Rev. mex. neurocienc. vol.24 no.5 Ciudad de México sep./oct. 2023  Epub 25-Sep-2023

https://doi.org/10.24875/rmn.23000027 

Original articles

Cognitive characteristics and quality of life in attention deficit hyperactivity disorder

Características cognitivas y calidad de vida en el Trastorno por Déficit de Atención con Hiperactividad

Arturo García-Galicia1 

Alejandra Aréchiga-Santamaría2 

Álvaro J. Montiel-Jarquín3 

María I. Pulido-Morales4 

Eduardo Vázquez-Cruz5 

Nancy R. Bertado-Ramírez6  * 

Marco A. González-Martínez1 

Jorge Loría-Castellanos7 

1Jefatura de División de Investigación en Salud, Unidad Médica de Alta Especialidad Hospital de Especialidades de Puebla, Centro Médico Nacional "Gral. de Div. Manuel Ávila Camacho", Instituto Mexicano del Seguro Social. Puebla, Puebla de Zaragoza

2Servicio de Neuropsicología, Centro de Atención Integral Infantil GARE. Puebla, Puebla de Zaragoza

3Dirección de Educación e Investigación en Salud, Unidad Médica de Alta Especialidad Hospital de Especialidades de Puebla, Centro Médico Nacional "Gral. de Div. Manuel Ávila Camacho", Instituto Mexicano del Seguro Social, Puebla, Puebla de Zaragoza

4Servicio de Pediatría, Hospital General de Zona Nº 20, Órgano Operador de Atención y Administración Descentralizada Puebla, Instituto Mexicano del Seguro Social, Puebla, Puebla de Zaragoza

5Unidad de Medicina Familiar n° 1, Órgano Operador de Atención y Administración Descentralizada Puebla, Instituto Mexicano del Seguro Social, Puebla, Puebla de Zaragoza

6Jefatura de División de Educación en Salud, Unidad Médica de Alta Especialidad Hospital de Especialidades de Puebla, Centro Médico Nacional "Gral. de Div. Manuel Ávila Camacho", Instituto Mexicano del Seguro Social, Puebla, Puebla de Zaragoza

7Dirección de Eventos Especiales, Instituto Mexicano del Seguro Social, Ciudad de México. Mexico


Abstract

Background:

Attention deficit hyperactivity disorder (ADHD) is the most frequent pediatric neurodevelopmental disorder. Studies in Mexico about health-related quality of life (QOL) and cognitive characteristics in these patients are scarce.

Objectives:

The objective of this study is to describe the relationship between cognitive characteristics and health-related QOL in children with ADHD in Puebla, Mexico.

Method:

A cross-sectional, analytical study was carried out in a second-level care hospital in Puebla, Mexico. Both genders, from 6 to 12 years old patients with ADHD were included. Those with visual/hearing disabilities and/or severe language delays were excluded. Patients who did not complete the information were eliminated. The Wechsler Intelligence Scale for Children IV (WISC-IV), The Neuropsi and Brief Multidimensional Life Satisfaction Scale for Students (as health-related QOL indicator) scales were applied. Spearman test was used; p ≤ 0.05 was considered significant.

Results:

104 children were recruited, 71 male (68.26%), medium age was 8.94 years old (SD = 1.83, min = 6, max = 12). Work memory and processing speed (WISC-IV), and memory and attention (Neuropsi) were the most affected domains. Health-related QOL was low at 60%. WISC-IVs intellectual quotient (r = 0.3962, p = 0.000), and Neuropsi's memory and attention (r = 0.451, p = 0.018) reported a significant moderated correlation with health-related QOL.

Conclusion:

Attention, memory, and processing speed were the most affected cognitive characteristics in children with attention deficit/hyperactivity disorder. Health-related QOL resulted low. Intellectual coefficient, as well as memory and attention, reported a significant moderated correlation with health-related QOL.

Keywords Neurodevelopmental disorders; Neuropsychology; Cognition; Intelligence

Resumen

Introducción:

El Trastorno por Déficit de Atención e Hiperactividad es el desorden pediátrico del neurodesarrollo más frecuente. Los estudios en México que evalúan Calidad de vida y características cognitivas son escasos.

Objetivo:

Describir la relación entre las características cognitivas y la calidad de vida en niños con trastorno por déficit de atención e hiperactividad en Puebla, México.

Método:

Se realizó un estudio transversal, analítico en un Hospital de 2º nivel de atención en Puebla, México. Se incluyeron pacientes con Trastorno por Déficit de Atención e Hiperactividad de 6 a 12 años. Se excluyeron aquellos con discapacidad visual/auditiva y retraso severo del lenguaje. Se eliminaron quienes no completaron la información. Se les aplicó WISC-IV, Neuropsi y BMSLSS (como indicador de Calidad de Vida). Se utilizó Coeficiente de Spearman; p ≤ 0.05 se consideró significativa.

Resultados:

104 niños reclutados, 71 hombres (68.26%), edad media 8.94 años (DE 1.83, mín. 6, máx. 12). Los dominios más afectados fueron Memoria de trabajo, Velocidad de procesamiento (WISC-IV), y Atención y memoria (Neuropsi). La Calidad de Vida fue mayoritariamente baja (60%). Coeficiente intelectual (WISC-IV) (r = 0.3962, p = 0.000) y Atención y memoria (Neuropsi) (r = 0.451, p = 0.018) reportaron correlación moderada significativa con Calidad de vida.

Conclusión:

Atención, Memoria y Velocidad de procesamiento son las características cognitivas más afectadas en niños con Trastorno por Déficit de Atención e Hiperactividad. La Calidad de vida es baja. Coeficiente intelectual y Atención y memoria reportaron correlación moderada significativa con Calidad de Vida.

Palabras clave Trastornos del Neurodesarrollo; Neuropsicología; Cognición; Inteligencia

Introduction

Attention deficit hyperactivity disorder (ADHD) is the most common neurodevelopmental disorder in the pediatric age group. This is a heterogeneous syndrome of multifactorial origin, characterized by moderate-to-severe distractibility, brief periods of attention, motor restlessness, emotional instability, and impulsivity1-4. It begins in childhood and up to 40-60% persists into adulthood, which affects psychosocial, school, and family functioning2. This has the prevalence in children of up to 41.1%, in adolescents and adults in 26.2%5. In Mexico, the prevalence is 14.6%3,6.

Executive functions are individual cognitive abilities that transform thoughts into decisions, plans, and actions. At least 4 functions are distinguished: Setting of objectives and planning, working memory, cognitive flexibility (task-switching ability), and inhibitory control. These altered functions characterize the patient with ADHD, and hinder family, school/work, and friendships social performance. It is frequently detected in the school because social interaction is evident in the group7-10.

The evaluation of executive functions is indispensable in the patient with suspicion or diagnosis of ADHD. It identifies strengths and opportunities to improve and allows to plan a psychobehavioral treatment with frequent evaluations of evolution10-13. The determining impact of ADHD on the quality of life (QOL) of children and adolescents is reflected in all areas of life and neurodevelopment13,14. This article evaluates the hypothesis about the correlation between cognition and QOL in children with ADHD.

The aim of this study was to describe the relationship between neuropsychological characteristics and QOL in children with ADHD in a second-level health care of the Mexican Social Security Institute in Puebla, Mexico.

Method

A prospective, analytical, and cross-sectional study was carried out. This work was approved by the Research Ethics Committee No. 21028 and the Local Health Research Committee No. 2102 of the Mexican Social Security Institute. All patients agreed to participate and their parents signed informed consent. They were given the possibility of not participating or leaving the study when they decided to do so. The individual results were given to the guardians and to the treating physicians. Personal data were handled with strict confidentiality.

Outpatients treated in a General Hospital of the Mexican Social Security Institute in Puebla, Mexico, were included. Patients were recruited with a diagnosis of ADHD established by neuropediatrician, (based on the criteria of the Diagnostic and Statistical Manual of Mental Disorders, fifth edition of the American Psychiatric Association DSM-5), of any gender, aged 6 to 12 years, who signed a letter of informed consent, and whose parents signed a letter of informed consent. Patients with visual or hearing impairment, severe delay in language development were excluded from this study. Those who did not complete the information and/or who requested to leave the study were eliminated from this study.

Patients who met the selection criteria received: Parental interview, and the Wechsler Intelligence Scale for Children IV (WISC-IV) and Neuropsi scales, which were applied by physicians trained for this purpose by neuropsychology.

The following instruments were applied:

  • − Interview with parents recording age, schooling, occupation, and behavioral disorders during childhood; about the patient: Perinatal history, time of diagnosis, sibling with ADHD, and treatment

  • WISC-IV it is essential for the diagnosis of intellectual disability, learning disorders, autism spectrum, ADHD, and others, including differential diagnoses. This identifies global intellectual capacity, general abilities, and a specific profile in patients aged 6-16 years, at primary school level to the beginning of high school. It has excellent consistency (α-Cronbach = 0.93) and validity. It consists of 15 tests (10 main and 5 optional) through which a profile of scalar scores, a total intellectual quotient (IQ) and four indices (verbal comprehension, perceptual reasoning, working memory, and processing speed) are obtained. Scores in each domain can be: Very high (130 and above), superior (120-129), high average (110-119), average (90-109), low average (80-89), borderline (70-79), and extremely low (69 and below)15

  • − Neuropsi attention and memory third edition (Neuropsi). Evaluates the cognitive subprocesses of: Attention and executive functions, memory, and global attention and memory. It has a consistency of 0.89-1, a sensitivity of 93% and a specificity of 98%. It is standardized for the Mexican population. The values can be: High normal range (116 points and above), normal (85-115 points), mild-to-moderate disturbances (70-84 points), or severe disturbances (69 points or less)16,17

  • − Brief multidimensional life satisfaction scale for students (BMSLSS). Self-report consists of 6 questions exploring different environments: family, friends, residence, school, personal, and general. It is widely used in Spanish-speaking populations. It reports high consistency (α-Cronbach = 0.85) and high concordance with other life satisfaction measures and related variables. One of 3 life satisfaction scores is obtained: High, Medium, and Low. Life satisfaction was used as an indicator of QOL12,18.

Statistical analysis

Descriptive statistics were used. Spearman's coefficient was used for the correlation between Neuropsi and WISC-IV with BMSLSS. The p ≤ 0.05 was considered significant. The statistical package SPSSv17.0 was used.

Results

Of the 148 patients in control with the diagnosis, 104 accomplished inclusion criteria, representing 70%. They were 33 (31.73%) females and 71 (68.27%) males, aged 6-12 years, with a mean of 8.94 (SD = 1.83).

The most frequent values in the patients were (Table 1): Age 8-10 years; 2nd and 3rd gestation; 1st-2nd and 3rd-4th grade schooling; time since diagnosis less than 3 years; no siblings with ADHD; pharmacotherapy with methylphenidate. There were 51 (49%) patients born in the first half of the year, and 53 (51%) were born in the second half. Only 10 (9.61%) patients reported siblings with ADHD, and only 5 (5%) received psychotherapy. The main comorbidities were sleep disorders (69 patients, 66.34%), epilepsy (67, 64.42%), and gastroesophageal reflux disease (61, 58.65%).

Table 1 Patient characteristics (n = 104) 

Age (years)
6-7 29.80%
8-10 50.00%
11-12 20.19%
Pregnancy number
20.19%
36.54%
39.42%
2.08%
2.08%
Academic degree
1º-2º Elementary 31.73%
3º-4º Elementary 34.61%
5º-6º Elementary 20.19%
1º High school 13.46%
Time to ADHDa Diagnosis (years)
< 3 57.69%
3-5 34.61%
> 5 7.69%
Pharmacological treatment
MPDb 77.88%
MPD+MVc 14.42%
MPD+risperidone 2.08%
MPD+sertraline 2.08%
Oxybutinin 2.08%
MV 2.08%

aADHD: attention deficit and hyperactivity disorder; bMPD: methylphenidate; cMV: magnesium valproate.

The most frequent values in mothers were (Table 2): Mean age 37 years, high school education, occupation homemakers, and behavioral disorders during childhood. For fathers: Age 38.56 years, high school, manual worker, and behavioral disorders in childhood.

Table 2 Characteristics of parents 

(n = 104) Father or tutor (n = 104) Mother or tutor
Medium age (years) 38.56 (±a 7.88 mínb 24, máxc 62) 37.02 (± 7.81, mín 24, máx 69)
Academic degree High school 53.84% (n = 56) High school 44.23% (n = 46)
College 22.11% (n = 23) Secondary school 29.80% (n = 31)
Secondary school 20.19% (n = 21) College 20.19% (n = 21)
Does not live with the family 3.84% (n = 4) Elementary school 5.76% (n = 6)
Occupation Manual worker 60.57% (n = 63) Housewife 55.76% (n = 58)
Professional 21.15% (n = 22) Professional 24.03% (n = 25)
Did not answer 14.42% (n = 15) Manual worker 20.19% (n = 21)
No contribution to the family 3.84% (n = 4)
Conduct disorders in childhood 22.11% (n = 23) 16.34% (n = 17)
Both 11.53% (n = 12)

a±: standard deviation;

bmín: minimum;

cmax: maximum

The most frequent findings in perinatal history were (Table 3) gestational risk: infections (frequently urinary), labor duration 8-10 and 12-19 h, apgar at 5 min 7-10, and in-hospital stay 0-3 days.

Table 3 Perinatal characteristics of patients (n = 104) 

History of gestational risk
Infections 54.80%
TA/TPTDa 45.19%
Alcohol/smoking 43.26%
Falls 23.07%
Accidents 3.84%
Other diseases 4.80%
Birth care
IMSSb 48.07%
Particular means 43.26%
Other public services 8.65%
Length of labor
2-4 hc
5-7 h 10.57%
8-10 h 29.80%
12-19 h 27.88%
24-48 h 3.84%
> 48 h 8.65%
Pregnancy outcome
Eutocic birth 50%
Cesarean delivery 50%
Apgar at 5 min
0-3 Bad 27.61%
4-6 Regular 6.73%
7-10 Good 65.38%
In-hospital stay after birth
0-3 days 77.88%
4-10 days 4.80%
15 days or more 17.30%

aTA/TPTD: Threatened abortion/Threatened Preterm Delivery;

bIMSS: Mexican Social Security Institute;

ch: hours.

The WISC-IV categories with the highest percentage were (Fig. 1): in verbal comprehension: Average and very high; in perceptual reasoning: Average and high average; and in working memory, processing speed and IQ: Average and low average.

Figure 1 Cognitive characteristics (WISC-IV) in children with attention deficit hyperactivity disorder.Scores in percentages of children on the Wechsler Intelligence Scale for Children IV (WISC-IV). n = 104. 

In Neuropsi, moda in the 3 domains (attention and executive functions, memory, and attention and memory) were the categories normal and mild alterations (Fig. 2).

Figure 2 Cognitive characteristics (Neuropsi) in children with attention deficit hyperactivity disorder.Results in percentages of patients in the Neuropsi Attention and Memory test 3rd ed (Neuropsi). n = 104. 

The BMSLSS results are detailed in figure 3. The highest frequencies were reported in the Horrible–Sad responses. The most frequent life satisfaction was low (59.61%), followed by medium (31.73%), and high (8.65%).

The correlation between IQ (WISC-IV) and life satisfaction (BMSLSS) was r = 0.3962 (p < 0.001). The correlation between attention and memory (Neuropsi) and life satisfaction (BMSLSS) was r = 0.451 (p = 0.018).

Figure 3 Quality of life in children with attention deficit hyperactivity disorder.Results in percentages by domain of the brief multidimensional life satisfaction scale for children (n = 104). 

Discussion

The prevalence of ADHD is high and progressive, and affects the cognitive performance of the carrier. Reports of cognitive characteristics in Mexico and Latin America with large samples are scarce13,18,19. In this study, the behavioral history of the parents, the most frequent diagnosis in 8-10 years, 3 years of evolution or less, and the management with methylphenidate are in agreement with other reports3,5,8-10,13,20,21. Some particularities differ from other reports: Less than 10% of siblings carriers of ADHD, and no differences in the demand for attention according to the semester of birth. This finding opposes to suggestions about the heritability near 75-80%, and about risks of misdiagnosis depending of the month of birth4,22. This confirms the role of the social-environmental context to develop this disorder.

Methylphenidate is the cornerstone in the treatment of ADHD, and improves QOL. Other pharmacological options are atomoxetine, lisdexamfetamine, and guanfacine. Treatment with oxybutynin, valproate, risperidone, and sertraline in this study indicates the broad spectrum of comorbidities20.

The presence of perinatal factors and childhood behavioral characteristics and disturbances in fathers and mothers in the present work represents the opportunities for prevention. The existence of more than one risk factor in several patients increases the possibility of neurological dysfunction, clinical variability, and vulnerability to ADHD. Youth, schooling, and parental occupation are conditions to be considered for comprehensive management1,3,5,12,21.

The higher prevalence of low mean and borderline scores in working memory and processing speed (WISC-IV), and attention and memory (Neuropsi) in this study is noteworthy. The ability to learn and transforming thoughts into actions starts with attention, is fixed with memory, and supports processing, including inhibition of impulsivity. These cognitive deficits are fundamental in ADHD. The importance of verbal comprehension/expression in this disorder is also established by other reports. The specific role of perceptual reasoning and other executive functions and their combinations remains to be investigated8,9,13,17,21.

In these patients, assessing the functional alteration of the individual and the results of the treatment is an essential and not only as symptomatological reduction. QOL is used for this purpose since the results in the physical, emotional, social, and cognitive dimensions are similar regardless of the instruments used to assess it23,24.

There are few studies in Mexico about QOL and cognition in patients with ADHD. In this study, life satisfaction was used as an indicator of QOL, as well as previous reports12,17. Pharmacotherapy generally improves the perception of QOL in these patients20,23,24. Despite all patients in this study receiving pharmacotherapy, 95% were not receiving psychotherapy in this study, and most reported low life satisfaction. This is alarming, and underscores the importance of combined drug and psychological treatment.

The lowest scores occurred in school, followed by friendships and housing, corresponding with reports from Latin America and Spain12,17,23-25. This is related to difficulties in the recognition of facial expressions and own and other people's emotions, which are essential skills for social relationships11,13,25,26. These deficits explain why children with ADHD perceive social rejection and poor acceptance by their peers10,27.

On the other hand, they may rate their cognitive and social competencies more positively than they actually do, which explains why the family environment and self-satisfaction received better evaluation12,27.

The IQ measured with WISC-IV is not an absolute parameter, it serves as a reference and patient labeling should be avoided. Although psychotherapy does not substantially modify it, it can optimize the evaluation score10,13. Like Neuropsi, it registered a moderate correlation with life satisfaction, both highly significant.

Only 5 patients of the sample (4.8%) received psychotherapy. Neuropsychological evaluation refines the diagnosis of the patient with ADHD, and behavioral follow-up is indispensable in comprehensive management. Psychoeducation and cognitive behavioral therapy optimize the performance of executive functions, self-esteem, and self-satisfaction. They support resilience and social performance, and decrease the probability of dissocial behaviors and future addictions10,13,17,19.

Although the present study is one of the largest samples among similar studies in this region3,9,13,17,19, it is still a limited population. Studies with more patients and multicenter studies are required to strengthen the conclusions. Another limitation is the omission of personal dimensions such as family functionality and/or parental characteristics, schools, and others.

Conclusions

Attention, memory, and processing speed are the cognitive characteristics most affected in children with ADHD. QOL is low, especially in school and friendship contexts. Psychobehavioral care strategies, together with pharmacotherapy, are essential to improve the patient's health status and prognosis.

References

1. Cardo E, Ros-Cervera G, Eirís-Puñal J, Escofet-Soteras C, Fernández-Jaén A, Mulas F, et al. Estado actual del enfoque del trastorno por déficit de atención/hiperactividad en neuropediatría. Rev Neurol. 2017;64:105-9. [ Links ]

2. Naranjo-Aristizábal MM, Salamanca-Duque LM, Jaramillo-Mestra R. Estrada-Peláez PA. Correlación entre discapacidad y calidad de vida en niños con trastorno por déficit de atención con hiperactividad. Rev Fac Med. 2019;67:293-8. [ Links ]

3. Cornejo-Escatell E, Fajardo-Fregoso BF, López-Velázquez VM, Soto-Vargas J, Ceja-Moreno H. Prevalencia de déficit de atención e hiperactividad en escolares de la zona noreste de Jalisco, México. Rev Méd. 2015;6:190-5. [ Links ]

4. Sánchez-Mascaraque P, Cohen DS. Trastorno por déficit de atención con hiperactividad en la infancia y adolescencia. Pediatr Integral. 2020;24:316-24. [ Links ]

5. Baggio S, Fructuoso A, Guimaraes M, Fois E, Golay D, Heller P, et al. Prevalence of attention deficit hyperactivity disorder in detention settings:a systematic review and meta-analysis. Front Psychiatry. 2018;9:331. [ Links ]

6. Rohde LA, Buitelaar JK, Gerlach M, Faraone SV. La Federación Mundial de TDAH Guía. 2019. 1st ed. Sao Paulo:Artmed Editora Brasil;2019. [ Links ]

7. Rodillo BE. Trastorno Por Déficit de Atención (TDAH) en Adolescentes. Rev Med Clin Condes. 2015;26:52-9. [ Links ]

8. Inmaculada-Navarro, M, García-Villamisar DA. Funcionamiento ejecutivo en el trastorno de déficit de atención con hiperactividad:una perspectiva ecológica de los perfiles diferenciales entre los tipos combinado e inatento. Rev Psicopatol Psicol Clin. 2011;16:113-24. [ Links ]

9. Lozano-Gutiérrez A, Ostrosky F. Desarrollo de las funciones ejecutivas y de la corteza prefrontal. Rev Neuropsicol Neuropsiquiat Neurociencias. 2011;11:159-72. [ Links ]

10. Abad-Mas L, Caloca-CataláO, Mulas F, Ruiz-Andrés R. Comparación entre el diagnóstico del trastorno por déficit de atención/hiperactividad con el DSM-5 y la valoración neuropsicológica de las funciones ejecutivas. Rev Neurol. 2017;64:95-100. [ Links ]

11. Quintero J, Martín M, Alcindor P, Pérez-Templado J. Prevención en el trastorno por déficit de atención/hiperactividad. Rev Neurol. 2016;62:93-7. [ Links ]

12. Miranda-Casas A, Presentación-Herrero MJ, Colomer-Diago C, RosellóB. Satisfacción con la vida en niños con trastorno por déficit de atención/hiperactividad:estudio de posibles factores de riesgo y de protección. Rev Neurol. 2011;52:119-26. [ Links ]

13. Pérez MA, Molina D, Gómez M. La intervención neuropsicológica en el tratamiento interdisciplinar para el TDAH. Neuropsicol Clín. 2016;1:14-29. [ Links ]

14. Cervigni MA, Stelzer F, Mazzoni CC, Gómez CD, Martino P. Funcionamiento ejecutivo y TDAH. Aportes teóricos para un diagnóstico diferenciado entre una población infantil y adulta. R Interam Psicol. 2012;46:271-76. [ Links ]

15. Wechsler D. Manual de Aplicación e Interpretación Del WISC-IV. 1st ed. Madrid España:TEA Ediciones;2005. [ Links ]

16. Ostrosky F, Gómez ME, Matute E, Rosselli M, Ardila A, Pineda D. Neuropsi Atención y Memoria. 3th ed. México, Ciudad de México:El Manual Moderno;2019. [ Links ]

17. Castillo-Parra G, Gómez Pérez E, Ostrosky-Solís F. Relación entre las funciones cognitivas y el nivel de rendimiento académico en niños. Rev Neuropsicol Neuropsiq Neurociencias. 2009;9:41-54. [ Links ]

18. Alfaro-Inzunza J, Guzmán-Piña J, García-Gómez C, Sirlopú-Díaz D, Gaudlitz-Ruiz L, Oyanedel-Sepúlveda JC. Propiedades psicométricas de la Escala Breve Multidimensional de Satisfacción con la Vida para Estudiantes (BMSLSS) en población infantil chilena (10-12 años). Univ Psychol. 2015;14:29-42. [ Links ]

19. Milla-Cano C, Gatica-Ferrero S. Memoria de trabajo y flexibilidad cognitiva en estudiantes con desarrollo típico y con trastorno por déficit de atención con hiperactividad. Avances Psicol Latinoamericana. 2020;38:1-15. [ Links ]

20. Jean-Tron MG, Márquez-González H, Barragán-Pérez E, Barajas-Nava A. Uso de metilfenidato en el trastorno por déficit de atención e hiperactividad. Bol Med Hosp Infant Mex. 2020;77:42-5. [ Links ]

21. Quintero-Gutiérrez-del-Álamo FJ, García-Campos N. Actualización en el Manejo del TDAH. Congreso de Actualización Pediatría 2019. Lúa Ediciones 3.0;2019. 29-36. [ Links ]

22. López-Villalobos JA, López-Sánchez MV, Andrés-de Llano JM. Trastorno por déficit de atención con hiperactividad:ritmo circanual en el Mes de nacimiento. Rev Psicol Clín Con Niños Adolesc. 2022;9:50-7. [ Links ]

23. Danckaerts M, Sonuga-Barke EJ, Banaschewski T, Buitelaar J, Döpfner M, Hollis C, et al. The quality of life of children with attention deficit/hyperactivity disorder:a systematic review. Eur Child Adolesc Psychiatr. 2010;19:83-105. [ Links ]

24. López-Villalobos JA, Sacristán-Martín AM, Garrido-Arredondo M, Martínez-Rivera MT, López-Sánchez MV, Rodríguez-Molinero L, et al. Calidad de vida relacionada con la salud en casos de trastorno por déficit de atención e hiperactividad con/sin tratamiento farmacológico. Ann Pediatr (Barc). 2019;90:272-9. [ Links ]

25. Baixauli-Fortea I, Berenguer-Forner C, Colomer C, Miranda-casas A, Roselló-Miranda B. Communicative skills in spanish children with autism spectrum disorder and children with attention deficit hyperactivity disorder. Analysis through parents'perceptions and narrative production. Res Autism Spectr Disord. 2018;50:22-31. [ Links ]

26. Buongiorno M, Vaucheret E, Giacchino M, Mayoni P, Polin A, Pardo-Campos M. Reconocimiento de emociones faciales en niños con trastorno por déficit de atención/hiperactividad. Rev Neurol. 2020;70:127-33. [ Links ]

27. López-Villalobos JA, Rodríguez-Molinero L, Sacristán-Martín AM, López-Sánchez MV, Garrido-Redondo M, Andrés-de Llano JM, et al. Calidad de vida en el trastorno por déficit de atención con hiperactividad:percepción de padres e hijos. Rev Pediatr Aten Primaria. 2021;23:e1-9. [ Links ]

FundingThe authors declare that this research has not received specific grants from agencies in the public, commercial, or non-profit sectors.

Ethical disclosures

Protection of human and animal subjects. The authors declare that the procedures followed were in accordance with the regulations of the relevant Clinical Research Ethics Committee and with those of the Code of Ethics of the World Medical Association (Declaration of Helsinki).

Confidentiality of data. The authors declare that they have followed the protocols of their work center on the publication of patient data.

Right to privacy and informed consent. The authors have obtained the written informed consent of the patients or their parents mentioned in the article. The corresponding author is in possession of this document.

Received: April 26, 2023; Accepted: July 27, 2023

* Correspondence: Nancy R. Bertado-Ramírez E-mail: nancy.bertado@imss.gob.mx

Conflicts of interest

The authors declare that they have no conflicts of interest.

Creative Commons License Instituto Nacional de Cardiología Ignacio Chávez. Published by Permanyer. This is an open ccess article under the CC BY-NC-ND license